BLOG

Adipose Stem Cell Therapy Side Effects: Safety Under Japanese Law

8 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Adipose-derived stem cell therapy is gaining attention as a promising option in regenerative medicine, utilizing the body’s own cells to support tissue repair and modulate inflammation. Because it uses autologous (your own) cells, many people assume it is free from side effects. However, like any medical procedure, it involves potential risks and side effects that are important to understand. This article provides a balanced overview of the potential side effects associated with adipose stem cell therapy and explains how patient safety is managed under Japan’s rigorous regulatory framework.

Understanding the Potential Side Effects of Adipose Stem Cell Therapy

The side effects of adipose-derived stem cell therapy can be broadly categorized into those related to the procedures for harvesting and administering the cells, and the body’s systemic response to the infusion. It’s important to note that most reported adverse events in clinical studies are mild and temporary.

1. Procedure-Related Side Effects:
These are linked to the two main steps of the treatment: fat collection and IV infusion.

  • At the Fat Collection Site: A small amount of fat tissue is collected, usually from the abdomen or thigh, under local anesthesia. Potential side effects at this site are similar to any minor surgical procedure and may include temporary pain, swelling, bruising, or numbness. The risk of infection is low when performed in a sterile clinical environment but is always a consideration.
  • At the IV Infusion Site: The cultured stem cells are returned to the body through an intravenous (IV) drip. Side effects are typically minor, such as pain or bruising at the needle insertion point.

2. Systemic Reactions After Infusion:
After the cells are infused, some individuals may experience a temporary systemic reaction. This is often part of the body’s normal response to the introduction of a large number of cells.

  • Post-Infusion Symptoms: Some patients report experiencing mild, short-term symptoms such as a low-grade fever, fatigue, headache, or chills. These symptoms typically resolve on their own within a day or two.

3. Theoretical and Rare Risks:
While the use of autologous cells significantly lowers the risk of rejection or severe allergic reactions, other theoretical risks are carefully considered. The risk of serious adverse events like blood clots (thromboembolism) has been discussed in the scientific community, but it is considered very rare, especially when proper administration protocols are followed. The long-term safety of stem cell therapies is a subject of ongoing research, and clinics operating under regulatory oversight are required to monitor and report any adverse events.

Ensuring Safety: How Japan Regulates Regenerative Medicine

Japan has one of the world’s most well-defined regulatory frameworks for regenerative medicine, established to ensure patient safety while promoting responsible innovation. The key legislation is the “Act on the Safety of Regenerative Medicine.” Clinics providing adipose stem cell therapy, including Grand Green Osaka Umekita Clinic, must comply with these strict standards.

  • Mandatory Treatment Plans: Before offering any regenerative therapy, a clinic must submit a detailed treatment plan to a government-certified committee for review. This plan outlines the entire process, from cell collection and processing to administration, including how potential risks and side effects will be managed. The therapy can only be provided after this plan is accepted by the Ministry of Health, Labour and Welfare.
  • Certified Cell Processing Facilities (CPFs): The cultivation and expansion of stem cells must be performed in a specialized facility that meets stringent government standards for safety, quality control, and hygiene. This minimizes the risk of contamination or errors during the cell culture process.
  • Informed Consent and Patient Monitoring: The law mandates that physicians provide patients with a thorough explanation of the treatment, including its expected benefits, potential risks, and alternative options. Treatment only proceeds after the patient gives their informed consent. Clinics are also required to monitor patients’ health after the procedure and have systems in place to manage and report any adverse events.

Key Questions to Ask Before Starting Treatment

A thorough consultation with a physician is essential to determine if adipose stem cell therapy is a suitable option for your individual health condition. This is your opportunity to have an open discussion and ensure you have realistic expectations. Here are some important questions to ask:

  • Based on my medical history, what are the specific risks and potential benefits for me?
  • How does the clinic manage potential side effects if they occur?
  • Can you explain the entire process, from the initial consultation to post-treatment follow-up?
  • What are the qualifications and experience of the medical team and the cell processing facility?
  • As this is a private treatment not covered by public health insurance, what are the total costs, including follow-up visits?

Consultation for Adipose Stem Cell Therapy in Osaka

At Grand Green Osaka Umekita Clinic, we provide adipose-derived stem cell therapy in strict compliance with Japan’s Act on the Safety of Regenerative Medicine. Our priority is patient safety, which is why we ensure every individual receives a comprehensive medical assessment to determine eligibility. We believe that an informed patient is best equipped to make decisions about their health. During the consultation, our physicians will discuss the treatment’s scientific basis, the procedural details, potential side effects, and the expected timeline and costs.

This treatment is a form of private (non-insured) medical care. A physician’s diagnosis is required to assess whether it is a suitable option for you. For more detailed information on our approach, the treatment flow, and associated risks, we encourage you to review our dedicated service page and schedule a consultation. Our clinic in Osaka is equipped to assist international patients, and further information is available on our English-language website.

For more details, please visit the Adipose-Derived Stem Cell Therapy page.

Conclusion: Making an Informed Decision

While adipose-derived stem cell therapy offers a promising approach in regenerative medicine, it is not without potential side effects. The majority of these are mild and transient, such as pain at the collection site or a temporary fever. Japan’s robust regulatory system provides a strong safety net by mandating strict protocols for cell processing, administration, and patient monitoring. The most crucial step for anyone considering this therapy is to have a detailed discussion with a qualified physician to understand how the potential risks and benefits apply to their unique situation. This ensures that any decision made is both informed and personalized.

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact